Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Semin Cancer Biol. 2021 Aug 18;77:99–109. doi: 10.1016/j.semcancer.2021.08.005

Figure 2. Biomarkers of platinum-resistant ovarian cancer.

Figure 2.

Molecular analysis of clinical specimens and laboratory studies have identified several molecular alterations associated with platinum-resistant ovarian cancer. These signature alterations can be exploited as molecular biomarkers to predict the nature of platinum resistance and monitor the response of ovarian cancer to therapy.